Global Pharma Tek

Executive Summary

Global Pharma Tek (GPT) is a US-based pharmaceutical services conglomerate offering workforce solutions, raw material trading/distribution, and drug development services (CRO, medical writing, regulatory, data management). Founded in 2011 and headquartered in Princeton, New Jersey, GPT serves as a diversified partner to the pharmaceutical industry, benefiting from increasing outsourcing trends. Its three-pronged business model provides revenue stability and cross-selling opportunities. The company is privately held, with no disclosed funding or valuation, but its comprehensive service portfolio positions it for steady growth as pharma companies seek to streamline operations. Key growth drivers include expansion of its CRO capabilities, geographic expansion in raw material sourcing, and potential adoption of AI in clinical data management.

Upcoming Catalysts (preview)

• Q3 2026Major CRO service contract win with top-20 pharma65% success
• Q4 2026Expansion of raw material distribution network into Asia-Pacific55% success
• Q2 2026Launch of AI-driven clinical data management platform50% success